z-logo
Premium
cDNA cloning of functional T cell receptor γ/δ chains expressed in human peripheral blood lymphocytes
Author(s) -
MamiChouaib Fathia,
Jitsukawa Setsuko,
Faure Florence,
Vasina Bruno,
Genevee Catherine,
Hercend Thierry,
Triebel FréDéRic
Publication year - 1989
Publication title -
european journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 201
eISSN - 1521-4141
pISSN - 0014-2980
DOI - 10.1002/eji.1830190905
Subject(s) - biology , microbiology and biotechnology , cloning (programming) , monoclonal antibody , complementary dna , phenotype , somatic cell , molecular cloning , epitope , gene , genetics , antibody , computer science , programming language
Abstract We have identified in earlier studies two V δ rearrangements corresponding to a 4.5‐kb Eco RI fragment detected with a V δ 1 probe and to a 7‐kb Eco RI band detected with a V δ 2 probe. These rearrangements have been found in two human T cell clones, F6C7 and G6, displaying surface phenotypes unfrequent in human peripheral blood, namely Ti γ A + BB3 ‐ (F6C7) and Ti γ A ‐ BB3 + (G6). Herein, we report the sequences of the functional transcripts encoded by these rearranged genes and show that the 4.5‐and the 7‐kb Eco RI fragments correspond to V1/D3/J δ 3 and to V2/D3/J δ 3 recombinations, respectively. In addition, we have sequenced the V2/D3/J1/C δ transcripts expressed in two clones, AB12 and VTC, which have a Ti γ A + BB3 + surface phenotype corresponding to that of most γ/δ peripheral lymphocytes. Analyses of the δ transcripts expressed by these four cells further strengthen the hypothesis that anti‐BB3 and anti‐δ‐TCS‐1 monoclonal antibodies recognize a V δ 2‐ and a V1/(D)/J δ 1‐encoded epitope, respectively. Sequence of the γ transcripts expressed by AB12 and F6C7 cells shows that they encode a V9/JP/C γ 1 chain. Finally, we confirm that non‐combinatorial diversity in the γ and δ proteins is generated by both junctional flexibility and N‐region addition without any somatic mutation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here